<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cerebral <z:hpo ids='HP_0000006'>Autosomal Dominant</z:hpo> <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">Arteriopathy</z:e> with Subcortical <z:mpath ids='MPATH_124'>infarcts</z:mpath> and <z:hpo ids='HP_0002352'>Leukoencephalopathy</z:hpo> (CADASIL) is the most prominent known cause of inherited <z:hpo ids='HP_0001297'>stroke</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> in human adult </plain></SENT>
<SENT sid="1" pm="."><plain>The disease gene, NOTCH3, encodes a transmembrane receptor primarily expressed in arterial smooth muscle cells (SMC) </plain></SENT>
<SENT sid="2" pm="."><plain>Pathogenic mutations lead to an odd number of <z:chebi fb="0" ids="32460">cysteine residues</z:chebi> within the NOTCH3 extracellular domain (NOTCH3(<z:mp ids='MP_0010412'>ECD</z:mp>)), and are associated with progressive accumulation of NOTCH3(<z:mp ids='MP_0010412'>ECD</z:mp>) at the SMC plasma membrane </plain></SENT>
<SENT sid="3" pm="."><plain>The murine homolog, Notch3, is dispensable for viability but required post-natally for the elaboration and maintenance of arteries </plain></SENT>
<SENT sid="4" pm="."><plain>How CADASIL-associated mutations impact NOTCH3 function remains a fundamental, yet unresolved issue </plain></SENT>
<SENT sid="5" pm="."><plain>Particularly, whether NOTCH3(<z:mp ids='MP_0010412'>ECD</z:mp>) accumulation may titrate the ligand and inhibit the <z:mpath ids='MPATH_458'>normal</z:mpath> pathway is unknown </plain></SENT>
<SENT sid="6" pm="."><plain>Herein, using genetic analyses in the mouse, we assessed the functional significance of an archetypal CADASIL-associated mutation (R90C), in vivo, in brain arteries </plain></SENT>
<SENT sid="7" pm="."><plain>We show that transgenic mouse lines expressing either the <z:mp ids='MP_0002169'>wild-type</z:mp> human NOTCH3 or the mutant R90C human NOTCH3, at comparable and physiological levels, can rescue the arterial defects of Notch3-/- mice to similar degrees </plain></SENT>
<SENT sid="8" pm="."><plain>In vivo assessment of NOTCH3/RBP-Jk activity provides evidence that the mutant NOTCH3 protein exhibits <z:mpath ids='MPATH_458'>normal</z:mpath> level of activity in brain arteries </plain></SENT>
<SENT sid="9" pm="."><plain>Remarkably, the mutant NOTCH3 protein remains functional and does not exhibit dominant negative interfering activity, even when NOTCH3(<z:mp ids='MP_0010412'>ECD</z:mp>) accumulates </plain></SENT>
<SENT sid="10" pm="."><plain>Collectively, these data suggest a model that invokes novel pathogenic roles for the mutant NOTCH3 protein rather than compromised NOTCH3 function as the primary determinant of the CADASIL <z:e sem="disease" ids="C0852949" disease_type="Disease or Syndrome" abbrv="">arteriopathy</z:e> </plain></SENT>
</text></document>